Skip to Content

Revatio Pfizer Inc. - Treatment for Pulmonary Arterial Hypertension

Revatio contains sildenafil citrate, the active ingredient in the erectile dysfunction medication Viagra. Revatio is indicated for the treatment of pulmonary arterial hypertension (PAH), a rare, aggressive and life-shortening vascular disease.

Posted: June 2005

Related Articles:

Revatio (sildenafil citrate) FDA Approval History

More News Resources

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.